WEBINAR Hit discovery against epigenetic targets 

Presentation by:
Dr. Saman Honarnejad – Director Drug Discovery at Pivot Park Screening Centre​

Topics:

• Trained immunity.
• The role of epigenetic targets in trained immunity.
• Hit discovery through ultra-High throughput screening of large libraries.
• Industry standard Hit-to-Lead (H2L) biological profiling frameworks.

Join us for this webinar in which we will focus on epigenetic targets:​
• Center for Open Innovation in LEad Discovery (COILED) is a collaborative drug discovery program focused on epigenetic targets.
• Modulation of trained innate immunity for treatment of hyper-inflammation and immune deficiency-driven diseases like sepsis and cancer.
• ultra-High Throughput Screening (uHTS) campaign of 300,000 diverse set of compounds has led to the identification of 3 novel scaffolds (starting points) that progressed into Hit-to-Lead (H2L) phase.

More information and registration